Georgetown Lombardi Comprehensive Cancer Center at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Georgetown Lombardi Comprehensive Cancer Center brings 1 presentation to SITC 2026 in Phoenix. Its program centres on combining VEGF blockade with checkpoint immunotherapy, including new bispecific drugs that hit VEGF and PD-1 or PD-L1 at once. Its most concrete focus is clinical results from pairing VEGF receptor blockers with immunotherapy in kidney cancer and other diseases.
| Organization | SITC 2026 Attendance |
|---|---|
Georgetown Lombardi Comprehensive Cancer Center Washington, DC | |
NCI-designated comprehensive cancer center of Georgetown University in Washington, DC. | Session Sun Nov 8 10:45am–12:25pm COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender?
Talk Sun Nov 8 11:15am–11:30am |
Instantly find 20 buyers from Georgetown Lombardi Comprehensive Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction